These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-001501-26 A randomized, double-blind pilot study vs placebo for the evaluation of the therapeutic effect of erythropoietin administered by iv route in patients whith diabetic neuropathy. bad-data
Not reported 2005-005873-31 A randomized, double-blind pilot study vs placebo for the evaluation of efficacy and tolerability of Erytropoietin administered by iv route as add-on treatment in patients affected by Amyotrophic Late... 2008-05-08 due-trials
Not reported 2005-005877-31 Phase II study Systemic treatment with ZK219477 EPOTHILONE in recurrent Glioblastoma patients 2008-03-05 due-trials
Not reported 2006-000032-27 MULTICENTRE RANDOMISED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF LONG-TERM ASCORBIC ACID TREATMENT IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A CMT-TRIAAL CMT-TRial Italian with Ascorbic Acid Long term 2010-04-30 due-trials
Not reported 2006-001039-23 A Pilot Phase II Study for the evaluation of efficacy and tolerability of Gammaidroxybutyrate (ALCOVER) administered by oral route as add on treatmant in patients affected by DYT 11 Myoclonic Dystonia... 2008-06-30 due-trials
Completed, but no date 2006-001204-36 Open pilot study for the evaluation of the analgesic effect of buprenorphine TDS administered as add-on treatment in patients with chronic neuropathic pain inadequately controlled by conventional ther... bad-data
Ongoing 2006-001858-27 A randomized, double-blind pilot study vs placebo for the evaluation of efficacy and tolerability of doxycline administered by oral route in patients affected by Creutzfeldt-Jakob disease. not-yet-due
Completed, but no date 2007-001088-32 A PHASE II RANDOMIZED, DOUBLE-BLIND STUDY VS. PLACEBO FOR THE EVALUATION OF EFFICACY AND TOLERABILITY OF SALBUTAMOL ADMINISTERED BY ORAL ROUTE IN PATIENTS AFFECTED BY SPINAL MUSCULAR ATHROPHY. bad-data
Ongoing 2007-001592-10 A randomized, double-blind pilot study vs. placebo for the evaluation of efficacy and tolerability of tauroursodeoxycholic acid administered by oral route as add on treatment in patients affected by a... not-yet-due
Ongoing 2007-002817-37 A PHASE II, PLACEBO CONTROLLED, DOSE FINDING PILOT STUDY OF PIXANTRONE EFFICACY ADMINISTERED INTRAVENOUSLY IN PATIENTS AFFECTED WITH MYASTHENIA GRAVIS not-yet-due
Completed, but no date 2007-003357-85 Randomized placebo-controlled double-blind trial to assess safety and efficacy of erythropoietin in adult patients with Friedreich's ataxia (a pilot study) bad-data
Completed, but no date 2007-004359-12 Simvastatin treatment in inclusion body myositis (IBM) bad-data
Completed, but no date 2008-000380-42 Radiotherapy and chemotherapy with cisplatin and temozolomide for patients affected by primary glioblastoma of new diagnosis bad-data
Completed, but no date 2008-001645-26 Phase II study: Systemic treatment with alternating weekly regimen of temozolomide and monthly fotemustine combination in recurrent glioblastoma patients. bad-data
Not reported 2008-003059-56 Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pantothenate Kinase-Associated Neurodegeneration – ICAND – Trial 2009-08-10 due-trials
Ongoing 2008-003905-15 Carmustine implant (Gliadel Wafer) plus adjuvant and concomitant Temozolomide in combination with radiotherapy in primary glioblastoma patients. not-yet-due
Completed, but no date 2009-013643-11 Neuroprotective effects of palmitoylethanolamide in diabetic neuropathy: a pilot study. bad-data
Ongoing 2009-015614-21 Stereotactic accelerated radiotherapy concurrent with Temozolomide chemotherapy in newly diagnosed glioblastoma not-yet-due
Ongoing 2009-016066-91 SAFETY AND EFFICACY OF ERYTHROPOIETIN IN AMYOTROPHIC LATERAL SCLEROSIS: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL not-yet-due
Ongoing 2011-001329-26 ErythroPOietin in ALS: a Study of dose-finding and Safety not-yet-due
Completed, but no date 2011-002527-18 Phase II, open label, monocentric, uncontrolled, non randomized clinical trial on Sodium Fluorescein for Surgery of High Grade Gliomas. bad-data
Ongoing 2012-000869-21 Pilot study: Imatinib for the treatment of plexiform neurofibromas in NF1 patients. not-yet-due
Completed, but no date 2013-004033-32 AN OPEN, MONOCENTRIC, NOT CONTROLLED CLINICAL TRIAL TO DEVELOP AND EVALUATE THE CLINICAL APPLICATION OF A NEW BETA PROBE FOR RADIOGUIDED SURGERY IN MENINGIOMA TUMOR bad-data
Ongoing 2014-005367-32 PROTEIN MISFOLDING, AMYOTROPHIC LATERAL SCLEROSIS AND GUANABENZ: A PHASE II RCT WITH FUTILITY DESIGN not-yet-due
Ongoing 2015-003127-62 A Randomized, Placebo-Controlled, Pilot Crossover Study to Evaluate the Effect of Amifampridine Phosphate (3,4-Diaminopyridine Phosphate) in Patients with MuSK Antibody Positive Myasthenia Gravis not-yet-due